JOHNSON & JOHNSON
JNJ
56 insider filings · Latest: Sep 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Feb 19 2:12 AM | Joseph J WolkExec VP, CFO | Sale | 89,654 | $242.80 | $21.8M | 14,000(D) | View → |
| Feb 17, 2026 | Feb 19 2:12 AM | REED JOHN CEVP, Innovative Medicine, R&D | Sale | 53,931 | $243.00 | $13.1M | 10,658(D) | View → |
| Feb 18, 2026 | Feb 19 2:11 AM | Timothy SchmidEVP, WW Chair, MedTech | Sale | 22,623 | $244.33 | $5.5M | 26,769(D) | View → |
| Feb 17, 2026 | Feb 19 2:11 AM | Vanessa BroadhurstEVP, Global Corp Affairs | Sale | 6,197 | $243.39 | $1.5M | 23,003(D) | View → |
| Feb 18, 2026 | Feb 18 4:14 PM | Schmid Timothy | Proposed Sale | 22,623 | $244.33 | $5.5M | — | View → |
| Feb 17, 2026 | Feb 17 9:10 PM | Broadhurst Vanessa | Proposed Sale | 6,197 | $243.39 | $1.5M | — | View → |
| Feb 17, 2026 | Feb 17 7:52 PM | Swanson James D. | Proposed Sale | 20,521 | $242.70 | $5.0M | — | View → |
| Feb 17, 2026 | Feb 17 7:43 PM | Wolk Joseph J | Proposed Sale | 89,654 | $242.80 | $21.8M | — | View → |
| Feb 17, 2026 | Feb 17 5:44 PM | REED JOHN C | Proposed Sale | 53,931 | $243.00 | $13.1M | — | View → |
| Feb 13, 2026 | Feb 13 7:33 PM | Swanson James D. | Proposed Sale | 41,559 | $243.73 | $10.1M | — | View → |
| Feb 5, 2026 | Feb 5 9:31 PM | Forminard Elizabeth | Proposed Sale | 6,226 | $237.90 | $1.5M | — | View → |
| Jan 26, 2026 | Jan 28 11:07 PM | Joaquin DuatoDirector, CEO and Chairman of the Board | Sale | 100,000 | $221.23 | $22.1M | 30,852(I) | View → |
| Jan 26, 2026 | Jan 26 9:57 PM | Joaquin Duato | Proposed Sale | 100,000 | $220.14 | $22.0M | — | View → |
| Oct 17, 2025 | Oct 17 2:23 PM | REED JOHN C | Proposed Sale | 21,721 | $192.71 | $4.2M | — | View → |
| Sep 4, 2025 | Sep 4 6:37 PM | Taubert Jennifer L | Proposed Sale | 56,471 | $177.81 | $10.0M | — | View → |
| Aug 29, 2025 | Aug 29 7:36 PM | Forminard Elizabeth | Proposed Sale | 9,570 | $177.20 | $1.7M | — | View → |
| Aug 22, 2025 | Aug 22 5:58 PM | Duato Joaquin | Proposed Sale | 125,824 | $180.04 | $22.7M | — | View → |
| Aug 15, 2025 | Aug 15 7:57 PM | Wolk Joseph J | Proposed Sale | 16,820 | $176.91 | $3.0M | — | View → |
| Jul 17, 2025 | Jul 17 8:05 PM | REED JOHN C | Proposed Sale | 19,137 | $163.55 | $3.1M | — | View → |
| Feb 25, 2025 | Feb 25 8:05 PM | Decker Robert J | Proposed Sale | 6,999 | $165.88 | $1.2M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Sep 11 12:51 AM | Daniel E PintoDirector | Grant/Award | 113.098 | — | 2,445.177(D) | View → |
| Sep 8, 2026 | Sep 11 12:50 AM | Eugene A. WoodsDirector | Grant/Award | 135.717 | — | 6,578.771(D) | View → |
| Sep 8, 2026 | Sep 11 12:50 AM | Marillyn A HewsonDirector | Grant/Award | 180.956 | — | 16,049.417(D) | View → |
| Sep 2, 2026 | Sep 4 1:08 PM | Timothy SchmidEVP, WW Chair, MedTech | Option Exercise | 33,597 | $151.41 | 0(D) | View → |
| Aug 17, 2026 | Aug 18 10:31 PM | Jennifer L TaubertEVP, WWC. Innovative Medicine | Option Exercise | 15,000 | $115.67 | 28,712(D) | View → |
| Aug 13, 2026 | Aug 14 8:35 PM | Joaquin DuatoDirector, CEO and Chairman of the Board | Option Exercise | 123,291 | $115.67 | 0(D) | View → |
| Aug 6, 2026 | Aug 7 9:44 PM | Elizabeth ForminardEVP, Chief Legal Officer | Option Exercise | 9,344 | $131.94 | 0(D) | View → |
| Jul 20, 2026 | Jul 21 9:27 PM | Vanessa BroadhurstEVP, Global Corp Affairs | Option Exercise | 23,054 | $131.94 | 0(D) | View → |
| Jun 11, 2026 | Jun 12 9:23 PM | Kathryn E WengelEVP, Chief TO and Risk Officer | Option Exercise | 10,000 | $115.67 | 32,965(D) | View → |
| Jun 9, 2026 | Jun 11 8:56 PM | Eugene A. WoodsDirector | Grant/Award | 161.089 | — | 6,411.959(D) | View → |
| Jun 9, 2026 | Jun 11 8:43 PM | Daniel E PintoDirector | Grant/Award | 134.241 | — | 2,320.824(D) | View → |
| Jun 9, 2026 | Jun 11 8:35 PM | Marillyn A HewsonDirector | Grant/Award | 214.786 | — | 15,791.877(D) | View → |
| May 1, 2026 | May 4 8:58 PM | REED JOHN CEVP, Innovative Medicine, R&D | Option Exercise | 25,255 | — | 0(D) | View → |
| Apr 23, 2026 | Apr 27 10:23 PM | Eugene A. WoodsDirector | Grant/Award | 975 | — | 6,215.094(D) | View → |
| Apr 23, 2026 | Apr 27 10:21 PM | Nadja WestDirector | Grant/Award | 975 | — | 7,730.049(D) | View → |
| Apr 23, 2026 | Apr 27 10:17 PM | Mark A WeinbergerDirector | Grant/Award | 975 | — | 12,010.408(D) | View → |
| Apr 23, 2026 | Apr 27 10:13 PM | Daniel E PintoDirector | Grant/Award | 1,712 | — | 2,174.069(D) | View → |
| Apr 23, 2026 | Apr 27 10:12 PM | John G MorikisDirector | Grant/Award | 1,540 | — | 1,540(D) | View → |
| Apr 23, 2026 | Apr 27 10:06 PM | Mark B. McclellanDirector | Grant/Award | 975 | — | 21,278.593(D) | View → |
| Apr 23, 2026 | Apr 27 10:05 PM | Hubert JolyDirector | Grant/Award | 975 | — | 9,183.605(D) | View → |
Page 1 of 4
Next →